← Leaderboards
Gabrielle Alexia Price
Icahn School Of Medicine At Mount Sinai
$146,660
Attributed
$146,660
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $54K · FY2022–24$100K$75K$50K$25K$0
'22
'23
'24
Funding mix
By agency
NIH$146,660 · 1
By mechanism
F31$146,660 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Dolores Hambardzumyan$10,720,002
- Makiko Yasuda$2,515,062
- Emily Bernstein$7,701,150
- Yizhou Dong$9,119,472
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectCell InjuryAggressive TherapyAminolevulinic AcidAdultApoptosisAstrocytesBehaviorBioinformaticsBloodAftercareAntitumor EffectBlood VesselsBrainBrain NeoplasmsBrain StemBromodeoxyuridineCancer CellCause Of DeathCell Culture TechniquesCell Cycle ArrestCell DeathBlood - Brain Barrier AnatomyCell Killing
Grant awards (3)
MEK PATHWAY INHIBITION COMBINED WITH 5-AMINOLEVULINIC ACID-PHOTODYNAMIC THERAPY FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA$53,974
F31 · FY2024 · CA · contact PI
MEK PATHWAY INHIBITION COMBINED WITH 5-AMINOLEVULINIC ACID-PHOTODYNAMIC THERAPY FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA$46,094
F31 · FY2023 · CA · contact PI
MEK PATHWAY INHIBITION COMBINED WITH 5-AMINOLEVULINIC ACID-PHOTODYNAMIC THERAPY FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA$46,592
F31 · FY2022 · CA · contact PI